Skin surface oxygen pressure fields during administration of prostaglandin E1 in patients with arterial occlusive disease
- 1 February 1990
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 68 (4) , 207-212
- https://doi.org/10.1007/bf01662716
Abstract
Summary Prostaglandin E1 is offered as a new therapeutic agent in the treatment of severe peripheral arterial occlusive disease. Especially when treating patients with ulcers or gangrene, the oxygen tension of the skin should improve during PGE1 administration. The new technique of assessing skin surface oxygen pressure histograms allows study of the skin microcirculation in vivo. Oxygen histograms were determined on the forefeet of 19 patients with different degrees of disease and different occlusion levels before and during a single intraarterial infusion of PGE1 at a dosage of 1.5 ng/kg body weight/min. Only 9 patients showed improvement during the infusion period. Skin oxygen pressure was increased to a large extent only in patients assumed to suffer from diabetic microangiopathy. The effect of a long-term therapy with PGE1 on skin microcirculation remains to be settled.Keywords
This publication has 11 references indexed in Scilit:
- Skin surface oxygen pressure in healthy volunteers and patients with arterial occlusive disease.1991
- Impaired Neurogenic Vascular Response in Patients with Diabetes and Neuropathic Foot LesionsNew England Journal of Medicine, 1988
- METABOLIC EFFECTS OF PROSTAGLANDIN-E1 ON HUMAN SKELETAL-MUSCLE1988
- Kontrollierte Zweizentren-Studie zur Wirksamkeit von intraarteriellen Prostaglandin E1-Infusionen bei peripherer arterieller Verschlußkrankheit im Stadium III und IVPublished by Springer Nature ,1988
- Blood flow in the foot, polyneuropathy and foot ulceration in diabetes mellitusDiabetologia, 1987
- Transcutaneous oxygen pressure measured at two different electrode core temperatures in healthy volunteers and patients with arterial occlusive disease.1987
- TRANS-CUTANEOUS PO-2 AND LASER DOPPLER FLOW WITH INCREASING DOSES OF INTRAARTERIALLY AND INTRAVENOUSLY ADMINISTERED PROSTAGLANDIN-E11987
- Prostaglandin E1 bei arterieller Verschlußkrankheit im Stadium III und IV: Ergebnisse einer multizentrischen StudieDeutsche Medizinische Wochenschrift (1946), 1987
- Effects of intra‐arterial prostaglandin E1 in patients with peripheral arterial occlusive diseaseEuropean Journal of Clinical Investigation, 1986
- Venous oxygenation in the diabetic neuropathic foot: Evidence of arteriovenous shunting?Diabetologia, 1982